Literature DB >> 8213447

Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience.

S Murali1, R L Kormos, B F Uretsky, D Schechter, P S Reddy, B G Denys, J M Armitage, R L Hardesty, B P Griffith.   

Abstract

The influence of preoperative transpulmonary pressure gradient (TPG) and pulmonary vascular resistance (PVR) on early post-transplant mortality was evaluated in 425 orthotopic transplant recipients. The overall 30-day post-transplant mortality rate was 12.5%; the majority of the deaths (52.8%) were due to primary allograft failure. The 0- to 2-day mortality rate was threefold higher in patients with severe preoperative pulmonary hypertension (TPG > or = 15 mm Hg or PVR > or = 5 Wood units), whereas the 3- to 7-day and 8- to 30-day mortality rates were similar. Early post-transplant mortality (0 to 2 days and 8 to 30 days) was also significantly higher (15.9% vs 3.9% and 9.9% vs 2.8%, respectively; p < 0.05) in women compared with men. Women with severe preoperative pulmonary hypertension had higher (p < 0.05) 0- to 2-day post-transplant mortality than comparable men. According to univariate analysis, recipients with preoperative TPG > or = 15 mm Hg had a significantly higher 30-day postoperative mortality rate, irrespective of their level of PVR. Furthermore, patients with severe preoperative pulmonary hypertension who underwent transplantation between 1980 and 1987 had a higher 0- to 2-day post-transplant mortality rate compared with patients operated on after that time. Multiple logistic regression analysis identified female recipient sex and preoperative TPG but not preoperative PVR, era of transplantation, or recipient age as significant (p < 0.001 and p < 0.01, respectively) independent predictors of early post-transplant mortality.

Entities:  

Mesh:

Year:  1993        PMID: 8213447     DOI: 10.1016/0002-8703(93)90704-d

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  21 in total

1.  Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities.

Authors:  Rajeev Saggar; Dinesh Khanna; Daniel E Furst; Shelley Shapiro; Paul Maranian; John A Belperio; Neeraj Chauhan; Philip Clements; Alan Gorn; S Sam Weigt; David Ross; Joseph P Lynch; Rajan Saggar
Journal:  Arthritis Rheum       Date:  2010-12

Review 2.  Pulmonary Hypertension Due to Left Heart Disease: an Update.

Authors:  Mandar A Aras; Mitchell A Psotka; Teresa De Marco
Journal:  Curr Cardiol Rep       Date:  2019-05-27       Impact factor: 2.931

Review 3.  Right heart catheterization and risk stratification in advanced heart failure.

Authors:  Michael Craig; Naveen L Pereira
Journal:  Curr Heart Fail Rep       Date:  2006-09

4.  Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children.

Authors:  M J Fenton; H Chubb; A M McMahon; P Rees; M J Elliott; M Burch
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

5.  [Heart and combined heart-lung transplantation. Indications, chances and risks].

Authors:  T Puehler; S Ensminger; U Schulz; U Fuchs; K Tigges-Limmer; J Börgermann; M Morshuis; K Hakim; O Oldenburg; J Niedermeyer; A Renner; J Gummert
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

6.  Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers.

Authors:  Aaron W Trammell; Meredith E Pugh; John H Newman; Anna R Hemnes; Ivan M Robbins
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

7.  Hemodynamic predictors of mortality in adults with sickle cell disease.

Authors:  Alem Mehari; Shoaib Alam; Xin Tian; Michael J Cuttica; Christopher F Barnett; George Miles; Dihua Xu; Catherine Seamon; Patricia Adams-Graves; Oswaldo L Castro; Caterina P Minniti; Vandana Sachdev; James G Taylor; Gregory J Kato; Roberto F Machado
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

8.  Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes.

Authors:  Justin Godown; David W Bearl; Cary Thurm; Matt Hall; Brian Feingold; Jonathan H Soslow; Bret A Mettler; Andrew H Smith; Elizabeth L Profita; Tajinder P Singh; Debra A Dodd
Journal:  Pediatr Transplant       Date:  2019-04-11

Review 9.  Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies.

Authors:  Luca Longobardo; Christopher Kramer; Scipione Carerj; Concetta Zito; Renuka Jain; Valentin Suma; Vinay Thohan; Nasir Sulemanjee; Frank X Downey; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

10.  High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension.

Authors:  Ivan M Robbins; Anna R Hemnes; Meredith E Pugh; Evan L Brittain; David X Zhao; Robert N Piana; Pete P Fong; John H Newman
Journal:  Circ Heart Fail       Date:  2013-12-02       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.